Mach5 Therapeutics is a biotechnology company that offers medicines intended for immune-mediated inflammatory and fibrotic diseases.
Mach5 Therapeutics has raised $19.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2024.
Mach5 Therapeutics is headquartered in Atlanta, United States.
Mach5 Therapeutics is a biotechnology company that offers medicines intended for immune-mediated inflammatory and fibrotic diseases.
Mach5 Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mach5 Therapeutics — Funding & Investors." VCBacked, November 4, 2024, https://www.vcbacked.co/company/mach5-therapeutics. Accessed November 13, 2026.
VCBacked. (2024). Mach5 Therapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/mach5-therapeutics
{{cite web |title=Mach5 Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mach5-therapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Mach5 Therapeutics? Request a listing update